Cell BiologyBlood AdvancesPeer-reviewed
The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy
Matthew W. Hagen, Nicollette J. Setiawan, Shannon L. Dexter…·Christina Marie Termini
This study shows CD45-targeted astatine-211 radioimmunotherapy more severely impairs hematopoietic recovery and reprograms bone marrow endothelial cells compared to non-targeted radiation.
1 citation